Skip to content

Clinical evaluation of traditional Chinese medicine foot bath combined with antibiotics in the treatment of children with bacterial pneumonia

Clinical evaluation of traditional Chinese medicine foot bath combined with antibiotics in the treatment of children with bacterial pneumonia

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2200006510
Enrollment
Unknown
Registered
2022-08-19
Start date
2022-08-21
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bacterial pneumonia in children

Interventions

Experimental group:Traditional Chinese Medicine Foot Bath Treatment
Control group:Simulant foot bath

Sponsors

The First Affiliated Hospital of Henan University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
3 Years to 5 Years

Inclusion criteria

Inclusion criteria: ?Comply with the above-mentioned western medicine diagnostic criteria and TCM syndrome differentiation criteria; ?3<Age =5 years old, gender is not limited; ?Can be admitted to hospital for routine treatment; ?The legal guardian of the child informed and agreed to receive treatment.

Exclusion criteria

Exclusion criteria: ? Confirmed or suspected pneumonia caused by non-community-acquired bacterial pathogens; ? Non-infectious causes of pulmonary infiltration, such as pulmonary embolism, chemical pneumonia caused by inhalation, etc.; ? Pleural empyema (excluding non-purulent pneumonic pleural effusion); ? Including but not limited to pneumonia complicated by bronchial asthma, bronchial foreign body, pneumonia complicated by measles, whooping cough, influenza, pneumonia complicated by other serious primary lung diseases; ? Those who are allergic to ß-lactam antibiotics in the past; ? Those who used antibiotics within 72 hours before enrollment; ?Have a history of epilepsy or convulsions in the past, except those with clearly recorded febrile convulsions in children; ? Infection may require simultaneous use of systemic corticosteroids; ? There is evidence of immediate life-threatening disease, including but not limited to current or imminent respiratory failure, acute heart failure, shock, acute liver failure, active gastrointestinal bleeding; ? Patients with primary diseases such as heart, liver, kidney, digestive and hematopoietic systems; ? Pneumonia combined with skin damage and trauma below the knee joint; ? Those who have skin allergies to traditional Chinese medicine decoction; ? Any situation that the researchers believe will compromise the safety of the patient or the quality of the data; ? Those who are unable or unwilling to comply with the procedures and restrictions specified by the study.

Design outcomes

Primary

MeasureTime frame
days of antibiotic use;hs-CRP;Clinical cure rate;

Secondary

MeasureTime frame
WBC;Incidence of reaching the indication for ICU transfer;Disease efficacy;Complete fever reduction days;complete fever reduction rate;Therapeutic effects of TCM syndromes;

Countries

China

Contacts

Public ContactJianli Qiu
qiujianli@126.com18100332690

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026